Judge Gregory Sleet of the US District Court for the District of Delaware lately decided in favor of Sanofi-Aventis in Uroxatral patent lawsuit and ruled that Sanofi’s US Patent Number 4,661,491 is valid and infringed by generic alfuzosin versions from Aurobindo Pharma and Torrent Pharma Inc. Earlier in May 2010, same judge rejected Mylan’s obviousness invalidation arguments and ruled Mylan’s generic alfuzosin infringing the ‘491 patent.
Labels: 'Patent-Drug Regulatory' Linkage, 107A (b), Alfuzosin, Aurobindo, Mylan, Sanofi, Torrent, Uroxatral
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home